Medigen Biotechnology Corp. (3176.TWO)

TWD 31.7

(-0.94%)

Annual Balance Sheets

(In TWD)
Breakdown 2023 2022 2021 2020 2019 2018
Total Assets 8.52 Billion 9.98 Billion 8.19 Billion 6.15 Billion 4.82 Billion 4.59 Billion
Total Current Assets 5.7 Billion 6.73 Billion 4.91 Billion 3.02 Billion 1.31 Billion 1.55 Billion
Cash And Short Term Investments 4.58 Billion 5.07 Billion 2.99 Billion 2.26 Billion 916.11 Million 1.16 Billion
Cash and Cash Equivalents 2.22 Billion 2.04 Billion 2.14 Billion 2.2 Billion 813.69 Million 590.76 Million
Short Term Investments 2.36 Billion 3.03 Billion 853.59 Million 54.2 Million 102.42 Million 576.88 Million
Net Receivables 386.67 Million 463.9 Million 811.5 Million 281.72 Million 151.24 Million 93.03 Million
Inventory 546.9 Million 692.61 Million 752.87 Million 323.29 Million 135.26 Million 130.83 Million
Other Current Assets 186.94 Million 501.5 Million 355.72 Million 155.89 Million 109.49 Million 165.13 Million
Total Non-Current Assets 2.81 Billion 3.24 Billion 3.28 Billion 3.13 Billion 3.51 Billion 3.04 Billion
Net PPE 2.04 Billion 2.19 Billion 2.18 Billion 2.16 Billion 2.54 Billion 2.24 Billion
Good Will And Intangible Assets 106.53 Million 113.07 Million 124.25 Million 155.51 Million 76.17 Million 80.46 Million
Good Will 76.17 Million 76.17 Million 76.17 Million 76.17 Million 76.17 Million 80.46 Million
Intangible Assets 30.36 Million 36.89 Million 48.07 Million 79.33 Million - -
Long-Term Investments 292.86 Million 307.33 Million 391.5 Million 156.49 Million 222.46 Million 30.92 Million
Tax Assets 327.49 Million 480.93 Million 522.17 Million 555.67 Million 519.2 Million 522.57 Million
Other Non Current Assets 49.09 Million 150.42 Million 53.95 Million 97.02 Million 158.56 Million 160.76 Million
Other Assets - 1.00 - - - -
Total Liabilities 3.53 Billion 3.51 Billion 1.77 Billion 1.65 Billion 2.14 Billion 1.65 Billion
Total Current Liabilities 2.77 Billion 1.05 Billion 1.06 Billion 933.8 Million 930.45 Million 665.11 Million
Account Payables 75.86 Million 150.23 Million 119.44 Million 65.61 Million 26.51 Million 26.55 Million
Tax Payables 24.62 Million 22.99 Million - - - -
Short Term Debt 2.19 Billion 404.75 Million 369.15 Million 522.4 Million 578.55 Million 437.38 Million
Deferred Revenue 134.99 Million 130.39 Million 244.42 Million 113.92 Million 101.88 Million 85.93 Million
Other Current Liabilities 373.99 Million 366.92 Million 331.88 Million 231.86 Million 223.5 Million 115.24 Million
Total Non Current Liabilities 750.22 Million 2.45 Billion 708.48 Million 719.15 Million 1.21 Billion 992.14 Million
Long-Term Debt 449.09 Million 2.12 Billion 470.77 Million 486.36 Million 846.01 Million 955.17 Million
Deferred Revenue Non Current 267.53 Million 275.31 Million 196.63 Million 195.66 Million 255 Thousand -
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 19.44 Million 40.22 Million 26.72 Million 18.96 Million 344.81 Million 11.05 Million
Other Liabilities 1.00 - - 1.00 - -
Total Equity 4.99 Billion 6.47 Billion 6.42 Billion 4.49 Billion 2.68 Billion 2.94 Billion
Stock Holders Equity 1.59 Billion 2.19 Billion 2.39 Billion 1.81 Billion 1.36 Billion 1.53 Billion
Common Stock 1.39 Billion 1.39 Billion 1.39 Billion 1.38 Billion 1.38 Billion 1.38 Billion
Retained Earnings 166.65 Million 598.97 Million 839.53 Million 166.95 Million -293.4 Million -107.81 Million
Accumulated other comprehensive income 11.34 Million 184.44 Million 152.68 Million 269.02 Million 283.24 Million 258.22 Million
Common Stock Equity 1.59 Billion 2.19 Billion 2.39 Billion 1.81 Billion 1.36 Billion 1.53 Billion
Capital Lease Obligation 267.53 Million 275.31 Million 196.63 Million 195.66 Million 333.45 Million -
Total Investments 2.65 Billion 3.34 Billion 1.24 Billion 210.69 Million 324.88 Million 607.81 Million
Total Debt 2.91 Billion 2.8 Billion 1.03 Billion 1.2 Billion 1.75 Billion 1.39 Billion
Net Debt 688.73 Million 768.6 Million -1.1 Billion -1 Billion 944.33 Million 801.79 Million

Balance Sheet Charts